Quality of Life and Utility in Patients with Metastatic Soft Tissue and Bone Sarcoma: The Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) Study

Table 4

EQ-5D utility values and VAS scores by health state.

	Statistic	EQ-5D utility^1	VAS score^2
Health state 1	N	17	17
1st-line chemotherapy	Mean (SD)	0.72 (0.31)	68.82 (14.44)
	Median	0.76	70
	Min, max	−0.08, 1	30, 85
	95% CI	0.56, 0.88	61.4, 76.25
Health state 2	N	22	23
2nd-line chemotherapy	Mean (SD)	0.64 (0.33)	65.04 (18.91)
	Median	0.73	70
	Min, max	−0.08, 1	15, 85
	95% CI	0.49, 0.78	56.86, 73.22
Health state 3	N	12	12
3rd-line chemotherapy	Mean (SD)	0.77 (0.14)	63.75 (17.9)
	Median	0.75	64
	Min, max	0.59, 1	40, 90
	95% CI	0.68, 0.86	52.38, 75.12
Health state 4	N	28	28
Progressive disease	Mean (SD)	0.56 (0.27)	50.79 (22.55)
	Median	0.66	50
	Min, max	0.08, 1	0, 100
	95% CI	0.46, 0.67	42.04, 59.53
Health state 5	N	35	36
Off chemotherapy, preprogression	Mean (SD)	0.77 (0.14)	74.56 (16.03)
	Median	0.76	77
	Min, max	0.52, 1	39, 100
	95% CI	0.73, 0.82	69.13, 79.98

Note: ¹Utility values range from −0.59 (worse than death)—1 (full health); ²VAS score range-from 0 to 100.